Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. - Wikidata - wikimedia - TriplyDB

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

http://www.wikidata.org/entity/Q37638645

about

Strategies to reduce hepatitis C virus recurrence after liver transplantation Impact of new treatment options for hepatitis C virus infection in liver transplantation Viral Vaccines and CTL Response Management of hepatitis C infection before and after liver transplantation Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.Antiviral treatment for hepatitis C virus infection after liver transplantation.The ongoing impacts of hepatitis c--a systematic narrative review of the literature Management of recurrent hepatitis C virus after liver transplantation.Paediatric models in motion: requirements for model-based decision support at the bedside.High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.Living-donor liver transplantation and hepatitis C Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Living donor liver transplantation for hepatitis C.Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.Treatment of hepatocellular carcinoma: beyond international guidelines.Treatment of hepatocellular carcinoma: beyond international guidelines.Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study.Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation.Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis.New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C.CXCL10 levels identify individuals with rapid fibrosis at 12 months post-transplant for hepatitis C virus and predict treatment response.Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey.REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.

P2860

Q22305418-21DB0987-37F3-4EB5-A7FA-FB358D645012 Q26782017-FAFAF6A2-33FF-4409-96CB-9CB9477CA257 Q27491330-C9D3E7C3-2F05-4679-A32A-B0D216D0E877 Q28081250-2814A5F3-A6A6-4B40-A8EC-32163397E619 Q28483065-45AB72FB-440E-4003-9B91-B53947DD3A6E Q33659942-CFFEAC4C-BE83-4E9F-AC78-1931178AFE7B Q34067940-B4EF1911-D390-4610-9CEA-B798EFC30CBA Q34340293-D7571527-1CED-4957-8251-61BA19962DE2 Q34383139-533FA602-04A1-4A89-8FC1-6DF5F4CEADAA Q34589655-D80F0D39-D0EE-470E-BD8F-970F2A264601 Q34953686-A2571AA5-B851-479D-AEFF-B3A15449C0CF Q35193285-44523378-D138-45FA-A20F-47E7B4EF4298 Q35773603-7C5376F6-058C-4028-AB28-BE9205B4A14C Q36587253-926319A6-7788-4B44-802B-DF138ACEC695 Q36745425-FF77D36C-82B9-46FD-9EC9-074F99A5E4E6 Q36880485-7BB4B759-0218-4A5D-BA8B-912E01B4CF4D Q37311439-D93F1BB3-1B79-4600-A788-C5B92BA4CEC8 Q37654458-94005DD7-3EC2-4A30-946A-4E61CE0E14E6 Q37777154-DC26F738-CC59-40BC-91EB-587A8E08DD6C Q37973516-4BD6B62A-E0EA-4049-B955-EBBEA7FFAA3C Q38050972-8DDB937A-857E-44BB-958E-BC1052E3C320 Q38081919-188A0FDB-F8EE-4142-A0B2-96120DCDD5FF Q38183336-C94CDD94-D096-4E7F-AD58-9BF38C397A47 Q38295870-DEC27FF0-6EA9-4C96-8808-7742A1EFB2A9 Q38685608-9C15AB19-3645-4934-93BA-29D260BCF61D Q39968802-051E33CE-8237-4565-B3BE-DB0B361A812B Q40356307-BD82E981-D1EB-4908-9957-5CD604D44317 Q40385837-9D11D2D1-47A7-47D6-B39D-FA6B162E7B10 Q40787483-22F6FD2C-CEFC-46B1-B07E-2DD441936AB4 Q40936812-73C01642-540C-49DB-B6AF-50DFD19B1C97 Q41172899-228AD874-F132-4C03-AEBF-E409587C2FEB Q41610405-2E852E7D-156B-441C-A7A4-307ED2D912B9 Q42024851-89EBE626-D7C9-41B3-97E1-31B1EAD319ED Q42214820-3D758A1B-3B8A-4159-8482-AB79877E54E5 Q42223349-29F7535A-154A-4D6B-832A-DD75423F91F6 Q42227943-15BCE431-F71D-4B34-B435-0B8D773AF2CD Q42241628-844A32CA-CD02-45CE-9128-53F608947AFF Q42260788-80D983D3-2B39-4714-910E-47AFB2781DCD Q44131130-FAF452D0-C158-4AFA-B46C-6E8D660D3D48 Q45358749-2D9B0AE8-1CF1-4D7C-B161-17BAF83AC68B

P2860

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

http://www.wikidata.org/entity/Q37638645

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Natural history of post-liver ...... that may influence its course.

@en

Natural history of post-liver ...... that may influence its course.

@nl

type

label

Natural history of post-liver ...... that may influence its course.

@en

Natural history of post-liver ...... that may influence its course.

@nl

prefLabel

Natural history of post-liver ...... that may influence its course.

@en

Natural history of post-liver ...... that may influence its course.

@nl

P1433

Q37638645-A4310FA7-9DCF-4E04-B253-0485A25A7524

P1476

Q37638645-2E29D7CD-21B8-4494-A36D-118EE954E56B

P2093

Q37638645-114D4A1A-9A77-41E1-9D4B-214AB93A0124

Q37638645-42873CE8-37A3-4422-93B1-FB8B01E94EFC

Q37638645-45E9E41F-FE82-4982-BB5C-0C407A4D0526

Q37638645-4D8AD081-0AA7-41F7-BD38-EB17FD894412

Q37638645-519A1B54-5E42-41AB-B25D-C1D824FA1236

Q37638645-5CF80836-95C5-4168-9C6C-423709032146

Q37638645-6499F978-2695-455E-98FC-A5F1B058B245

Q37638645-A4DC035A-8E9A-448C-93C0-984CC238ACE6

Q37638645-B809D585-1E56-4F5F-BD04-CF5A7E6562E8

Q37638645-CB8D77A5-571E-4FF8-AB68-E5477C568375

P304

Q37638645-FCE6EAC7-5BAC-4FF3-AD1F-E25D46CC8483

P31

Q37638645-D9CBA490-FD5D-4DDD-8978-46BBEEDE1F71

P356

Q37638645-A6CFD659-9F07-450E-AD95-70741BCF3769

P433

Q37638645-C3156C3E-8079-42DB-A5D7-57CDE319AAAD

P478

Q37638645-74445DF6-8DA6-408B-9D3C-77C6950C99CB

P50

Q37638645-1DE504A4-D96C-418C-9296-090FECBEF414

Q37638645-843D2D4D-576C-4C2B-9DC5-92870ED2661F

P577

Q37638645-B191CE6A-2C80-4D4F-B010-15AD539A1DB7

P5875

Q37638645-CC5840E8-5A8A-4071-8770-1E5BAAE2904A

P698

Q37638645-576E1803-B1DA-4EAF-84FC-188687355755

P921

Q37638645-A7BE8794-A248-4EC4-A2EE-14E82B327EC9

P356

P1433

Liver Transplantation

P1476

Natural history of post-liver ...... that may influence its course

@en

P2093

Adyr Moss

http://www.w3.org/2001/XMLSchema#string

Amir Yosephy

http://www.w3.org/2001/XMLSchema#string

Bashar A Aqel

http://www.w3.org/2001/XMLSchema#string

Brie Noble

http://www.w3.org/2001/XMLSchema#string

David D Douglas

http://www.w3.org/2001/XMLSchema#string

David Mulligan

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Carey

http://www.w3.org/2001/XMLSchema#string

James W Williams

http://www.w3.org/2001/XMLSchema#string

Jorge Rakela

http://www.w3.org/2001/XMLSchema#string

Juan F Gallegos-Orozco

http://www.w3.org/2001/XMLSchema#string

P304

1872-1881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.21954

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni De Petris

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40031367

http://www.w3.org/2001/XMLSchema#string

P698

19938138

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation